SNG Consulting provides specialty-matched medical case reviews that combine an evidence-based evaluation of the treatment in question with an expert opinion. The reviews support rapid healthcare decisions and promote cost-effective interventions, while meeting the applicable mandates. Clinical queries address experimental and/or investigational status of interventions, medical necessity or appropriateness, off-label use, and the evaluation of alternative therapies. The reviews may involve complex diagnoses, disabling, progressive conditions and terminal illnesses. International, European, and national health plan-specific clinical criteria or guidelines are systematically considered.
Dr. Simona Nistor-Grahl acts on behalf of Cochrane Clinical Answers (CCA) editors as Clinical Advisor for clinical answers in hematology/oncology and psychiatry. Examples of authored CCAs include:
AMSP e.V. Projekt
Since 1993, the AMSP project (i.e. Germ. Arzneimittelsicherheit in der Psychiatrie) systematically documents and analyzes adverse drug reactions of psychotropic drugs with the aim of increasing the safety of treatment through documentation and further education.
MAGSC - Clinics and Hospitals members of the Mayo Alumni German Speaking Chapter
Founded by Rudolf Juchems, M.D., the Mayo Alumni German Speaking Chapter (MAGSC) hosted its first scientific meeting in Bonn in 1996 (reported on in Mayo Alumni magazine, Fall 2005, Volume 41, No 4, 14-15). Dr. Juchems was a cardiologist specializing in internal Intensive Care Medicine and a member and board member of numerous scientific societies in Germany and abroad. He was a member of the Doctors Mayo Society and the Plummer Society as well as a honorary member of the European Council of Emergency Medical Care and Resuscitation Medicine. Dr. Juchems passed away in 2008 and the annual MAGSC scientific award is named in his honor.
As a member of the Special Interest Group Clinical Pharmacometrics we are involved in the Education Task Force and support medical universities with sources and guidance for curriculum development, mentoring activities, and drug safety research (incl. disease progression modeling projects).